Xiaoping Chen
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Job Satisfaction and Organizational Behavior
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 5
-
- Antiplatelet Therapy and Cardiovascular Diseases 14
- Co-authors
- Douglas J. Sego (1 shared paper)Chun Hui (1 shared paper)Wei Zhang (23 shared papers)Hong‐Hao Zhou (19 shared papers)Zhaoqian Liu (18 shared papers)Hong‐Hao Zhou (11 shared papers)Mu-Peng Li (18 shared papers)Jie Tang (12 shared papers)
- Journals
- PLoS ONE (5 papers)Scientific Reports (5 papers)European Journal of Clinical Pharmacology (4 papers)Frontiers in Pharmacology (4 papers)Frontiers in Cardiovascular Medicine (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoping Chen
187 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 179
- Cancer Research 493
- Organizational Behavior and Human Resource Management 309
- Pharmacology 226
- Cardiology and Cardiovascular Medicine 397
- Infectious Diseases 306
Countries citing papers authored by Xiaoping Chen
This map shows the geographic impact of Xiaoping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Chen more than expected).
Fields of papers citing papers by Xiaoping Chen
This network shows the impact of papers produced by Xiaoping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Chen. The network helps show where Xiaoping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 193 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 372 | |
| 2 | 2020 | 312 | |
| 3 | 2004 | 190 | |
| 4 | 2011 | 155 | |
| 5 | 2017 | 129 | |
| 6 | 2010 | 114 | |
| 7 | 2022 | 78 | |
| 8 | 2017 | 77 | |
| 9 | 2017 | 74 | |
| 10 | 2014 | 70 | |
| 11 | 2016 | 69 | |
| 12 | 2019 | 65 | |
| 13 | 2010 | 54 | |
| 14 | 2016 | 52 | |
| 15 | 2019 | 51 | |
| 16 | 2013 | 49 | |
| 17 | 2010 | 46 | |
| 18 | 2012 | 45 | |
| 19 | 2018 | 44 | |
| 20 | 2010 | 44 |
About Xiaoping Chen
Xiaoping Chen is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Epidemiology, Cancer Research and Physiology, having authored 193 papers that have together received 4.1k indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Cancer-related molecular mechanisms research (9 papers), RNA modifications and cancer (8 papers), Hepatitis B Virus Studies (7 papers), Liver Disease Diagnosis and Treatment (6 papers), Epigenetics and DNA Methylation (5 papers), Platelet Disorders and Treatments (5 papers) and Alcohol Consumption and Health Effects (5 papers). The work is most often cited by research in Cancer Research (493 citations), Organizational Behavior and Human Resource Management (309 citations), Pharmacology (226 citations), Cardiology and Cardiovascular Medicine (397 citations) and Infectious Diseases (306 citations). Xiaoping Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Douglas J. Sego, Chun Hui, Wei Zhang, Hong‐Hao Zhou, Zhaoqian Liu, Hong‐Hao Zhou, Mu-Peng Li, Jie Tang, Hong‐Hao Zhou and Yuan‐Jian Li. Their work appears in journals such as PLoS ONE, Scientific Reports, European Journal of Clinical Pharmacology, Frontiers in Pharmacology and Frontiers in Cardiovascular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.